Study uncovers key processes behind MYC cancer gene
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
List view / Grid view
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
The structure of a key receptor involved in tumour metastasis has been imaged in a study, providing opportunities to develop cancer treatments.
A study has revealed a drug target for skin cancers which regulates the differentiation of cells and the roles they conduct in the body.
Researchers have revealed a key inflammation mechanism that contributes to melanoma brain metastasis and could be a therapeutic target.
New findings show that the environment for pancreatic cancers plays a role in its metastasis, revealing a new potential drug target.
A new study has revealed that glioblastomas contain four different types of cell which the researchers say should be treated separately.
Using a compound called PTC596 in combination with other drugs, researchers effectively treated pancreatic cancer in mice.
A study has found that signals from interferons can be blocked, allowing the immune system to attack tumours which provides a potential target.
Researchers have identified the process behind cancer cell energy production, providing a drug target for treatments to inhibit growth.
Researchers have discovered the mechanism behind a gateway into cells for glutamine, illuminating potential ways to prevent cancer cells from getting nutrients.
A study has discovered that reducing expression of a key gene in neuroblastoma tumourigenesis is an important drug target for the condition.
Researchers have discovered a non-coding RNA which could be used as a biomarker and in new therapies for prostate cancer.
Researchers have found that fat cells transfer cytokines to melanoma cells, which transforms them into aggressive tumours, indicating a drug target for the condition.
A new study has found a novel way to target an enzyme involved in cancer growth, which could inform therapeutics for the condition.
Researchers have identified a protein that plays a role in promoting blood cancer and have successfully used a novel compound to inhibit it, reducing tumour growth.